| 中文名称 | (1S,4aS,5R,7S,7aS)-4a,5-二羟基-7-甲基-1-(((2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)-1,4a,5,6,7,7a-六氢环戊二烯并[c]吡喃-7-基肉桂酸酯 |
|---|---|
| 中文别名 | 哈巴俄甙 ;哈巴俄苷 |
| 英文名称 | (1S,4aS,5R,7S,7aS)-4a,5-Dihydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl cinnamate |
| 英文别名 | Harpagosid;8'-CINNAMOYLHARPAGIDE;8-O-E CINNAMOYL HARPAGIDE;HARPAGOSIDE;[1S-[1alpha,4aalpha,5alpha,7alpha(E),7aalpha]]-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-[(allyl-1-oxo-3-phenyl)oxy]cyclopenta[c]pyran-1-yl-beta-D-glucopyranoside;Harpogoside;HARPAGOSIDE hplc;[(1S,4aS,5R,7S,7aS)-4a,5-Dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate;HARPAGOSIDE WITH HPLC;7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl;β-D-Glucopyranoside, (1S,4aS,5R,7S,7aS)-1,4a,5,6;[(1S)-1,4a,5,6,7,7aα-Hexahydro-4aα,5α-dihydroxy-7-methyl-7α-[[(E)-1-oxo-3-phenyl-2-propenyl]oxy]cyclopenta[c]pyran-1α-yl]β-D-glucopyranoside;b-D-Glucopyranoside,(1S,4aS,5R,7S,7aS)-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-[[(2E)-1-oxo-3-phenyl-2-propen-1-yl]oxy]cyclopenta[c]pyran-1-yl;HARPAGOSIDE(P);HARPAGOSIDE(RG);Einecs 242-881-6;[ "" ];side;Harpa;Harpagoside ,98%;8KGS1DC5ZU;SMR001233395;Harpaside;E-harpagoside;Prestwick3_000988;BSPBio_001055;MLS002473324;MLS002154086;BPBio1_001161;MEGxp0_000469;Harpagoside, analytical standard;KVRQGMOSZKPBNS-FMHLWDFHSA-N;HMS2231N12;HMS2098E17;[(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[ |
| CAS号 | 19210-12-9 |
| 分子式 | C24H30O11 |
| 分子量 | 494.49 |
微信公众号
版权所有：济南迈纳科技有限公司 未经授权禁止拷贝本站资料，如有违反,将追究法律责任
备案号： 鲁ICP备2021031564号-1 危险品化学品经营许可证 营业执照
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
